ERIC A. ROSE MD - 20 Jul 2023 Form 4 Insider Report for Orchestra BioMed Holdings, Inc. (OBIO)

Role
Director
Signature
/s/ Matthew R. Schob, Attorney-in-Fact
Issuer symbol
OBIO
Transactions as of
20 Jul 2023
Net transactions value
$0
Form type
4
Filing time
24 Jul 2023, 17:09:11 UTC
Previous filing
19 May 2023
Next filing
21 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OBIO Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 20 Jul 2023 Common Stock 25,000 $7.42 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.